The prognostic value of NSE and S100B from serum and cerebrospinal fluid in patients with spontaneous subarachnoid hemorrhage

Journal of Neurosurgical Anesthesiology

Volumn 22, Issue 1, 2010, Pages 21-31

  Moritz, Stefan ^a   Warnat, Jan ^a   Bele, Sylvia ^a   Graf, Bernhard Martin ^a   Woertgen, Chris ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

Author keywords

Neuron specific enolase; S100B; Subarachnoid hemorrhage

Indexed keywords

DIPYRONE; NEURON SPECIFIC ENOLASE; NIMODIPINE; PARACETAMOL; PROTEIN S100B;

ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; BRAIN INFARCTION; BRAIN VASOSPASM; CEREBROSPINAL FLUID; DIAGNOSTIC ACCURACY; GLASGOW OUTCOME SCALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTHERMIA; INTENSIVE CARE UNIT; INTRACRANIAL HYPERTENSION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PILOT STUDY; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SUBARACHNOID HEMORRHAGE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; CEREBRAL INFARCTION; DRAINAGE; FEMALE; GERMANY; HUMANS; INTRACRANIAL HYPERTENSION; MALE; MIDDLE AGED; NERVE GROWTH FACTORS; PHOSPHOPYRUVATE HYDRATASE; PILOT PROJECTS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPRODUCIBILITY OF RESULTS; ROC CURVE; S100 PROTEINS; SUBARACHNOID HEMORRHAGE; TREATMENT OUTCOME; VASOSPASM, INTRACRANIAL; YOUNG ADULT;

EID: 75149112301     PISSN: 08984921     EISSN: None     Source Type: Journal    
DOI: 10.1097/ANA.0b013e3181bdf50d     Document Type: Article

References (35)

1. Svensson E, Starmark JE. Evaluation of individual and group changes in social outcome after aneurysmal subarachnoid haemorrhage: a long-term follow-up study. J Rehabil Med. 2002;34:251-259.
2. Schievink WI, Schaid DJ, Michels VV, et al. Familial aneurysmal subarachnoid hemorrhage: a community-based study. J Neurosurg. 1995;83:426-429.
3. Schievink WI. Intracranial aneurysms. N Engl J Med. 1997;336:28-40.
4. Rosen DS, Macdonald RL. Subarachnoid hemorrhage grading scales: a systematic review. Neurocrit Care. 2005;2:110-118.
5. van Norden AG, van Dijk GW, van Huizen MD, et al. Interobserver agreement and predictive value for outcome of two rating scales for the amount of extravasated blood after aneurysmal subarachnoid haemorrhage. J Neurol. 2006;253:1217-1220.
6. Pleines UE, Morganti-Kossmann MC, Rancan M, et al. S-100 beta reflects the extent of injury and outcome, whereas neuronal specific enolase is a better indicator of neuroinflammation in patients with severe traumatic brain injury. J Neurotrauma. 2001;18:491-498.
7. Raabe A, Kopetsch O, Woszczyk A, et al. Serum S-100B protein as a molecular marker in severe traumatic brain injury. Restor Neurol Neurosci. 2003;21:159-169.
8. Rothoerl RD, Woertgen C, Brawanski A. S-100 serum levels and outcome after severe head injury. Acta Neurochir Suppl. 2000;76:97-100.
9. Woertgen C, Rothoerl RD, Brawanski A. Early S-100B serum level correlates to quality of life in patients after severe head injury. Brain Inj. 2002;16:807-816.
10. Woertgen C, Rothoerl RD, Metz C, et al. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma. 1999;47:1126-1130.
11. Sanchez-Pena P, Pereira AR, Sourour NA, et al. S100B as an additional prognostic marker in subarachnoid aneurysmal hemorrhage. Crit Care Med. 2008;36:2267-2273.
12. Weiss N, Sanchez-Pena P, Roche S, et al. Prognosis value of plasma S100B protein levels after subarachnoid aneurysmal hemorrhage. Anesthesiology. 2006;104:658-666.
13. Teasdale GM, Drake CG, Hunt W, et al. A universal subarachnoid hemorrhage scale: report of a committee of the World Federation of Neurosurgical Societies. J Neurol Neurosurg Psychiatry. 1988; 51:1457.
14. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet. 1975;1:480-484.
15. Fisher CM, Kistler JP, Davis JM. Relation of cerebral vasospasm to subarachnoid hemorrhage visualized by computerized tomographic scanning. Neurosurgery. 1980;6:1-9.
16. Muley T, Ebert W, Stieber P, et al. Technical performance and diagnostic utility of the new Elecsys neuron-specific enolase enzyme immunoassay. Clin Chem Lab Med. 2003;41:95-103.
17. Hallen M, Carlhed R, Karlsson M, et al. A comparison of two different assays for determining S-100B in serum and urine. Clin Chem Lab Med. 2008;46:1025-1029.
18. Zweig MH, Campbell G. Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine. Clin Chem. 1993;39:561-577.
19. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143: 29-36.
20. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
21. Hardemark HG, Almqvist O, Johansson T, et al. S-100 protein in cerebrospinal fluid after aneurysmal subarachnoid haemorrhage: relation to functional outcome, late CT and SPECT changes, and signs of higher cortical dysfunction. Acta Neurochir (Wien). 1989; 99:135-144.
22. Persson L, Hardemark HG, Gustafsson J, et al. S-100 protein and neuron-specific enolase in cerebrospinal fluid and serum: markers of cell damage in human central nervous system. Stroke. 1987;18: 911-918.
23. Takayasu M, Shibuya M, Kanamori M, et al. S-100 protein and calmodulin levels in cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg. 1985;63:417-420.
24. Hoefnagel D, Dammers R, Ter Laak-Poort MP, et al. Risk factors for infections related to external ventricular drainage. Acta Neurochir (Wien). 2008;150:209-214; discussion 214.
25. Wiesmann M, Missler U, Hagenstrom H, et al. S-100 protein plasma levels after aneurysmal subarachnoid haemorrhage. Acta Neurochir (Wien). 1997;139:1155-1160.
26. Kacira T, Kemerdere R, Atukeren P, et al. Detection of caspase-3, neuron specific enolase, and high-sensitivity C-reactive protein levels in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. Neurosurgery. 2007;60:674-679; discussion 679-680.
27. Mabe H, Suzuki S,MaseM, et al. Serum neuron-specific enolase levels after subarachnoid hemorrhage. Surg Neurol. 1991;36:170-174.
28. Oertel M, Schumacher U, McArthur DL, et al. S-100B and NSE: markers of initial impact of subarachnoid haemorrhage and their relation to vasospasm and outcome. J Clin Neurosci. 2006;13: 834-840.
29. Vos PE, van Gils M, Beems T, et al. Increased GFAP and S100beta but not NSE serum levels after subarachnoid haemorrhage are associated with clinical severity. Eur J Neurol. 2006;13:632-638.
30. Beer R, Lackner P, Pfausler B, et al. Nosocomial ventriculitis and meningitis in neurocritical care patients. J Neurol. 2008;255:1617-1624.
31. Nolan CP, Macdonald RL. Can angiographic vasospasm be used as a surrogate marker in evaluating therapeutic interventions for cerebral vasospasm? Neurosurg Focus. 2006;21:E1.
32. Vajkoczy P, Meyer B, Weidauer S, et al. Clazosentan (AXV-034343), a selective endothelin A receptor antagonist, in the prevention of cerebral vasospasm following severe aneurysmal subarachnoid hemorrhage: results of a randomized, double-blind, placebo-controlled, multicenter phase IIa study. J Neurosurg. 2005;103:9-17.
33. Todd MM, Hindman BJ, Clarke WR, et al. Mild intraoperative hypothermia during surgery for intracranial aneurysm. N Engl J Med. 2005;352:135-145.
34. Lanzino G, Kassell NF, Dorsch NW, et al. Double-blind, randomized, vehicle-controlled study of high-dose tirilazad mesylate in women with aneurysmal subarachnoid hemorrhage. part I. A cooperative study in Europe, Australia, New Zealand, and South Africa. J Neurosurg. 1999;90:1011-1017. (Pubitemid 29241166)
35. Lynch JR, Wang H, McGirt MJ, et al. Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage: results of a pilot randomized clinical trial. Stroke. 2005;36:2024-2026.